Norbert Nagel

Title: Norbert Nagel: Innovator in Pharmaceutical Cocrystals

Introduction

Norbert Nagel is a notable inventor based in Mörfelden-Walldorf, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel solid forms of agomelatine.

Latest Patents

Norbert Nagel holds a patent for "Pharmaceutically acceptable cocrystals of N-[2-(7-methoxyl-1-naphtyl)ethyl]acetamide and methods of their preparation." This invention relates to the creation of new solid forms of agomelatine, specifically focusing on pharmaceutically acceptable cocrystals. The patent outlines methods for preparing these cocrystals, which exhibit physico-chemical properties suitable for pharmaceutical development. He has successfully obtained three such cocrystals.

Career Highlights

Norbert Nagel is associated with Zentiva K.S., where he continues to contribute to pharmaceutical innovations. His work has been instrumental in advancing the understanding and application of cocrystals in drug formulation.

Collaborations

Norbert has collaborated with notable colleagues, including Gary James Miller and Ludek Ridvan, enhancing the research and development efforts within his field.

Conclusion

Norbert Nagel's innovative work in pharmaceutical cocrystals exemplifies the importance of research and development in the medical field. His contributions are paving the way for advancements in drug formulation and delivery.